SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.28 Million USD | -58.72% |
| 2022 | 2.13 Million USD | 129.16% |
| 2021 | -7.25 Million USD | -238.17% |
| 2020 | 5.41 Million USD | -42.59% |
| 2019 | 9.21 Million USD | -43.68% |
| 2018 | 15.95 Million USD | 84.85% |
| 2017 | 8.81 Million USD | 79.43% |
| 2016 | -520.74 Thousand USD | 185.64% |
| 2015 | -8.57 Million USD | -170.77% |
| 2014 | 8.85 Million USD | 1835.53% |
| 2013 | 7.87 Million USD | 25.16% |
| 2012 | -583.76 Thousand USD | -104.63% |
| 2011 | 10.7 Million USD | 6.71% |
| 2010 | 12.69 Million USD | -1.94% |
| 2009 | 12.94 Million USD | 13.81% |
| 2008 | 11.37 Million USD | -75.06% |
| 2007 | 45.74 Million USD | 370.23% |
| 2006 | 9.7 Million USD | 1968.66% |
| 2005 | 469 Thousand USD | 127.46% |
| 2004 | -1.7 Million USD | -155.64% |
| 2003 | 3.07 Million USD | -73.66% |
| 2002 | 11.65 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -103.5 Thousand USD | 90.31% |
| 2024 Q2 | -103.5 Thousand USD | 0.0% |
| 2023 Q1 | -469 Thousand USD | -362.34% |
| 2023 Q3 | -680.33 Thousand USD | -68.03% |
| 2023 Q2 | -404.88 Thousand USD | 13.67% |
| 2023 Q4 | -1.06 Million USD | -57.02% |
| 2023 FY | - USD | -58.72% |
| 2022 Q2 | 2.47 Million USD | 106.75% |
| 2022 Q3 | -1.04 Million USD | -142.4% |
| 2022 FY | - USD | 129.16% |
| 2022 Q4 | -101.44 Thousand USD | 90.34% |
| 2022 Q1 | 1.19 Million USD | -44.03% |
| 2021 FY | - USD | -238.17% |
| 2021 Q2 | 1.05 Million USD | 0.0% |
| 2021 Q1 | 1.05 Million USD | -58.3% |
| 2021 Q3 | 891.83 Thousand USD | -15.83% |
| 2021 Q4 | 2.13 Million USD | 139.9% |
| 2020 Q2 | 3.37 Million USD | 143.61% |
| 2020 Q3 | 761.66 Thousand USD | -77.41% |
| 2020 FY | - USD | -42.59% |
| 2020 Q4 | 2.54 Million USD | 233.55% |
| 2020 Q1 | 1.38 Million USD | -60.82% |
| 2019 Q2 | 6.12 Million USD | 103.88% |
| 2019 Q1 | 3 Million USD | 2.64% |
| 2019 Q3 | 1.05 Million USD | -82.77% |
| 2019 FY | - USD | -43.68% |
| 2019 Q4 | 3.53 Million USD | 234.7% |
| 2018 Q4 | 2.92 Million USD | 199.11% |
| 2018 Q2 | 12.83 Million USD | 99.21% |
| 2018 Q1 | 6.44 Million USD | 851.2% |
| 2018 FY | - USD | 84.85% |
| 2018 Q3 | 979 Thousand USD | -92.37% |
| 2017 Q1 | 2.89 Million USD | 123.21% |
| 2017 FY | - USD | 79.43% |
| 2017 Q4 | -857.5 Thousand USD | 0.0% |
| 2017 Q3 | -857.5 Thousand USD | -129.57% |
| 2017 Q2 | 2.89 Million USD | 0.0% |
| 2016 Q3 | 1.29 Million USD | 1504.32% |
| 2016 Q1 | -92.5 Thousand USD | 97.6% |
| 2016 Q2 | -92.5 Thousand USD | 0.0% |
| 2016 FY | - USD | 185.64% |
| 2016 Q4 | 1.29 Million USD | 0.0% |
| 2015 FY | - USD | -170.77% |
| 2015 Q4 | -3.85 Million USD | 0.0% |
| 2015 Q3 | -3.85 Million USD | -370.98% |
| 2015 Q2 | 1.42 Million USD | -40.91% |
| 2015 Q1 | 2.4 Million USD | 7396.97% |
| 2014 FY | - USD | 1835.53% |
| 2014 Q1 | 559 Thousand USD | -76.38% |
| 2014 Q2 | 1.98 Million USD | 255.64% |
| 2014 Q3 | 974 Thousand USD | -51.01% |
| 2014 Q4 | -33 Thousand USD | -103.39% |
| 2013 FY | - USD | 25.16% |
| 2013 Q4 | 2.36 Million USD | 722.89% |
| 2013 Q3 | -380 Thousand USD | -169.47% |
| 2013 Q2 | 547 Thousand USD | 7.05% |
| 2013 Q1 | 511 Thousand USD | 115.38% |
| 2012 Q3 | 15 Thousand USD | -86.61% |
| 2012 FY | - USD | -104.63% |
| 2012 Q4 | -3.32 Million USD | -22253.33% |
| 2012 Q1 | -38 Thousand USD | -102.76% |
| 2012 Q2 | 112 Thousand USD | 394.74% |
| 2011 FY | - USD | 6.71% |
| 2011 Q4 | 1.37 Million USD | -44.57% |
| 2011 Q3 | 2.48 Million USD | 18.27% |
| 2011 Q1 | 1.89 Million USD | 106.64% |
| 2011 Q2 | 2.1 Million USD | 10.81% |
| 2010 Q1 | 2.6 Million USD | 269.5% |
| 2010 Q4 | 918 Thousand USD | -62.02% |
| 2010 Q3 | 2.41 Million USD | -0.41% |
| 2010 FY | - USD | -1.94% |
| 2010 Q2 | 2.42 Million USD | -6.83% |
| 2009 Q4 | 705 Thousand USD | -81.03% |
| 2009 FY | - USD | 13.81% |
| 2009 Q3 | 3.71 Million USD | 57.43% |
| 2009 Q2 | 2.36 Million USD | -0.71% |
| 2009 Q1 | 2.37 Million USD | 0.0% |
| 2008 Q2 | 1.78 Million USD | 0.0% |
| 2008 FY | - USD | -75.06% |
| 2007 FY | - USD | 370.23% |
| 2006 FY | - USD | 1968.66% |
| 2005 FY | - USD | 127.46% |
| 2004 FY | - USD | -155.64% |
| 2003 FY | - USD | -73.66% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 110.494% |
| Augmedix, Inc. | -17.68 Million USD | 118.571% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 99.061% |
| CareCloud, Inc. | -31.29 Million USD | 110.494% |
| HealthEquity, Inc. | 282.41 Million USD | 98.837% |
| iCoreConnect Inc. | -11.87 Million USD | 127.64% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 98.24% |
| Nutex Health, Inc. | -14.58 Million USD | 122.519% |
| Omnicell, Inc. | 60.69 Million USD | 94.59% |
| OneMedNet Corporation | -11.97 Million USD | 127.429% |
| Progyny, Inc. | 64.46 Million USD | 94.907% |
| Renalytix Plc | -28.52 Million USD | 111.513% |
| Schrödinger, Inc. | -171.89 Million USD | 101.91% |
| Simulations Plus, Inc. | 6.13 Million USD | 46.444% |
| SOPHiA GENETICS SA | -70.7 Million USD | 104.644% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 125.62% |
| Ontrak, Inc. | -14.41 Million USD | 122.777% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 99.908% |
| Sharecare, Inc. | -67.25 Million USD | 104.882% |
| Aclarion, Inc. | -4.14 Million USD | 179.304% |
| CareMax, Inc. | -590.46 Million USD | 100.556% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 162.246% |
| Forian Inc. | 2.75 Million USD | -19.388% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 162.246% |
| HeartBeam, Inc. | 675 Thousand USD | -386.447% |
| GeneDx Holdings Corp. | -136.46 Million USD | 102.406% |
| SCWorx Corp. | -3.97 Million USD | 182.61% |
| Minerva Surgical, Inc. | -20.07 Million USD | 116.358% |
| Definitive Healthcare Corp. | -241.22 Million USD | 101.361% |
| 10x Genomics, Inc. | -205.11 Million USD | 101.601% |
| Zhongchao Inc. | -4.9 Million USD | 166.978% |
| Accolade, Inc. | -71.19 Million USD | 104.612% |
| MSP Recovery, Inc. | -69.22 Million USD | 104.744% |
| R1 RCM Inc. | 426.2 Million USD | 99.23% |
| Spok Holdings, Inc. | 26.29 Million USD | 87.514% |
| Privia Health Group, Inc. | 27.18 Million USD | 87.92% |
| EUDA Health Holdings Limited | -8.3 Million USD | 139.559% |
| TruBridge, Inc. | -15.39 Million USD | 121.334% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 99.061% |
| Sharecare, Inc. | -67.25 Million USD | 104.882% |
| Health Catalyst, Inc. | -66.46 Million USD | 104.94% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 96.983% |
| Premier, Inc. | 286.08 Million USD | 98.852% |
| HealthStream, Inc. | 59.58 Million USD | 94.49% |
| Certara, Inc. | 23.84 Million USD | 86.229% |
| GeneDx Holdings Corp. | -136.46 Million USD | 102.406% |
| Ontrak, Inc. | -14.41 Million USD | 122.777% |
| CareCloud, Inc. | -31.29 Million USD | 110.494% |
| EUDA Health Holdings Limited | -8.3 Million USD | 139.559% |
| HeartBeam, Inc. | 675 Thousand USD | -386.447% |
| Mangoceuticals, Inc. | -9.18 Million USD | 135.739% |
| CareMax, Inc. | -590.46 Million USD | 100.556% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 180.008% |
| National Research Corporation | 45.98 Million USD | 92.86% |
| Aclarion, Inc. | -4.14 Million USD | 179.304% |
| OptimizeRx Corporation | -21.3 Million USD | 115.409% |